• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性间歇性低氧促进肥胖患者非酒精性脂肪性肝炎的进展。

Chronic intermittent hypoxia contributes to non-alcoholic steatohepatitis progression in patients with obesity.

机构信息

Department of Endocrinology, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing, China.

Department of Endocrinology, Drum Tower Hospital Affiliated to Nanjing University Medical School, Nanjing, China.

出版信息

Hepatol Int. 2022 Aug;16(4):824-834. doi: 10.1007/s12072-022-10347-2. Epub 2022 Jun 6.

DOI:10.1007/s12072-022-10347-2
PMID:35668285
Abstract

BACKGROUND AND PURPOSE

The association between the severity of obstructive sleep apnea (OSA) and non-alcoholic fatty liver disease (NAFLD) in patients with obesity remains unclear. We conducted this study to determine the effects of OSA on the severity of NAFLD in individuals with obesity and its link to the development of non-alcoholic steatohepatitis (NASH).

METHODS

Patients were subjected to standard polysomnography up to 1 week before undergoing bariatric surgery, during which liver biopsy specimens were obtained. The apnea-hypopnea index (AHI) obtained by polysomnography was used to determine the severity of OSA.

RESULTS

In total, 183 patients with obesity and biopsy-confirmed NAFLD were included; 49 (27%) had NASH. Patients with NASH had higher AHIs (p = 0.014) and oxygen desaturation indices (p = 0.031), more frequent OSA (p = 0.001), and lower minimum oxygen saturation (p = 0.035). The severity of OSA was directly correlated with the NAFLD activity score (p < 0.001), NASH activity grade (p < 0.001), semi-quantitative indices of lobular inflammation (p = 0.001), and hepatocyte ballooning (p = 0.006). The odds ratios (95% confidence intervals) for NASH and severe NASH (activity grade ≥ 3) associated with moderate-to-severe OSA were 3.85 (1.35-10.94; p < 0.05) and 5.02 (1.66-15.18; p < 0.01), respectively, after adjusting for sex, age, body mass index, waist circumference, insulin resistance values, and metabolic syndrome.

CONCLUSIONS

Chronic intermittent hypoxia caused by OSA may aggravate NAFLD and lead to a higher risk of NASH in patients with obesity.

摘要

背景与目的

肥胖患者阻塞性睡眠呼吸暂停(OSA)严重程度与非酒精性脂肪性肝病(NAFLD)之间的关系尚不清楚。本研究旨在确定 OSA 对肥胖个体中 NAFLD 严重程度的影响及其与非酒精性脂肪性肝炎(NASH)发展的关系。

方法

患者在接受减重手术前 1 周内接受标准多导睡眠图检查,在此期间获取肝活检标本。多导睡眠图获得的呼吸暂停低通气指数(AHI)用于确定 OSA 的严重程度。

结果

共纳入 183 例肥胖且经肝活检证实为 NAFLD 的患者;其中 49 例(27%)患有 NASH。患有 NASH 的患者 AHI 更高(p=0.014)和氧减指数(p=0.031),更频繁地发生 OSA(p=0.001),且最低氧饱和度更低(p=0.035)。OSA 的严重程度与 NAFLD 活动评分(p<0.001)、NASH 活动分级(p<0.001)、小叶炎症的半定量指标(p=0.001)和肝细胞气球样变(p=0.006)呈直接相关。中重度 OSA 与 NASH 和重度 NASH(活动分级≥3)相关的比值比(95%置信区间)分别为 3.85(1.35-10.94;p<0.05)和 5.02(1.66-15.18;p<0.01),在调整性别、年龄、体重指数、腰围、胰岛素抵抗值和代谢综合征后。

结论

OSA 引起的慢性间歇性缺氧可能加重 NAFLD,并使肥胖患者发生 NASH 的风险增加。

相似文献

1
Chronic intermittent hypoxia contributes to non-alcoholic steatohepatitis progression in patients with obesity.慢性间歇性低氧促进肥胖患者非酒精性脂肪性肝炎的进展。
Hepatol Int. 2022 Aug;16(4):824-834. doi: 10.1007/s12072-022-10347-2. Epub 2022 Jun 6.
2
Insulin Resistance, but Not Obstructive Sleep Apnea Is Associated with Hepatic Steatosis in Chinese Patients with Severe Obesity.胰岛素抵抗而非阻塞性睡眠呼吸暂停与中国重度肥胖患者的肝脂肪变性有关。
Obes Facts. 2023;16(4):344-355. doi: 10.1159/000528789. Epub 2023 Feb 28.
3
The impact of obstructive sleep apnea on nonalcoholic fatty liver disease in patients with severe obesity.重度肥胖患者中阻塞性睡眠呼吸暂停对非酒精性脂肪性肝病的影响。
Obesity (Silver Spring). 2016 Apr;24(4):871-7. doi: 10.1002/oby.21409. Epub 2016 Feb 16.
4
Nonalcoholic fatty liver disease associated with obstructive sleep apnea: just a coincidence?非酒精性脂肪性肝病与阻塞性睡眠呼吸暂停相关:仅仅是巧合吗?
Obes Surg. 2010 Nov;20(11):1536-43. doi: 10.1007/s11695-010-0212-1.
5
Obstructive Sleep Apnea and Non-alcoholic Fatty Liver Disease in Obese Patients Undergoing Bariatric Surgery.肥胖患者接受减重手术后的阻塞性睡眠呼吸暂停与非酒精性脂肪性肝病。
Obes Surg. 2020 Jul;30(7):2572-2578. doi: 10.1007/s11695-020-04514-3.
6
Obstructive sleep apnea and liver injury in severely obese patients with nonalcoholic fatty liver disease.阻塞性睡眠呼吸暂停与非酒精性脂肪性肝病重度肥胖患者的肝损伤。
Sleep Breath. 2020 Dec;24(4):1515-1521. doi: 10.1007/s11325-020-02018-z. Epub 2020 Jan 30.
7
Association Between the Severity of Nocturnal Hypoxia in Obstructive Sleep Apnea and Non-Alcoholic Fatty Liver Damage.阻塞性睡眠呼吸暂停低通气综合征夜间低氧血症严重程度与非酒精性脂肪肝损伤的关系
Hepat Mon. 2015 Nov 28;15(11):e32655. doi: 10.5812/hepatmon.32655. eCollection 2015 Nov.
8
Obstructive sleep apnea syndrome affects liver histology and inflammatory cell activation in pediatric nonalcoholic fatty liver disease, regardless of obesity/insulin resistance.阻塞性睡眠呼吸暂停综合征可影响非酒精性脂肪性肝病患儿的肝组织学和炎症细胞激活,而与肥胖/胰岛素抵抗无关。
Am J Respir Crit Care Med. 2014 Jan 1;189(1):66-76. doi: 10.1164/rccm.201307-1339OC.
9
Non-alcoholic fatty liver disease is an independent risk factor for inflammation in obstructive sleep apnea syndrome in obese Asian Indians.非酒精性脂肪性肝病是肥胖的印度裔亚洲人阻塞性睡眠呼吸暂停综合征中炎症的独立危险因素。
Sleep Breath. 2019 Mar;23(1):171-178. doi: 10.1007/s11325-018-1678-7. Epub 2018 Jul 22.
10
Association between non-alcoholic fatty liver disease and obstructive sleep apnea.非酒精性脂肪性肝病与阻塞性睡眠呼吸暂停的关系。
World J Gastroenterol. 2020 May 28;26(20):2669-2681. doi: 10.3748/wjg.v26.i20.2669.

引用本文的文献

1
Associations Between Obstructive Sleep Apnea and Metabolic Dysfunction-Associated Fatty Liver Disease: Insights from Comprehensive Mendelian Randomization and Gene Expression Analysis.阻塞性睡眠呼吸暂停与代谢功能障碍相关脂肪性肝病之间的关联:来自综合孟德尔随机化和基因表达分析的见解
Nat Sci Sleep. 2025 Jul 8;17:1571-1585. doi: 10.2147/NSS.S511115. eCollection 2025.
2
Association Between Obstructive Sleep Apnea and Non-Alcoholic Fatty Liver Disease: Epidemiological Cross-Sectional Study and Mendelian Randomization Analysis.阻塞性睡眠呼吸暂停与非酒精性脂肪性肝病之间的关联:流行病学横断面研究与孟德尔随机化分析
Nat Sci Sleep. 2025 Jun 17;17:1361-1376. doi: 10.2147/NSS.S524675. eCollection 2025.
3

本文引用的文献

1
Increased liver stiffness in patients with severe sleep apnoea and metabolic comorbidities.严重睡眠呼吸暂停合并代谢合并症患者的肝硬度增加。
Eur Respir J. 2018 Jun 28;51(6). doi: 10.1183/13993003.00601-2018. Print 2018 Jun.
Sleep behaviors and metabolic-associated fatty liver disease.
睡眠行为与代谢相关脂肪性肝病
PLoS One. 2025 May 28;20(5):e0323715. doi: 10.1371/journal.pone.0323715. eCollection 2025.
4
Potential bidirectional communication between the liver and the central circadian clock in MASLD.非酒精性脂肪性肝炎中肝脏与中枢昼夜节律时钟之间潜在的双向通讯。
NPJ Metab Health Dis. 2025;3(1):15. doi: 10.1038/s44324-025-00058-1. Epub 2025 Apr 9.
5
Association between self-reported sleep apnea and biomarkers of liver injury: Evidence from National Health and Nutrition Examination Survey.自述睡眠呼吸暂停与肝损伤生物标志物之间的关联:来自国家健康和营养检查调查的证据。
Medicine (Baltimore). 2024 Sep 6;103(36):e39393. doi: 10.1097/MD.0000000000039393.
6
Association of Obstructive Sleep Apnea with Nonalcoholic Fatty Liver Disease: Evidence, Mechanism, and Treatment.阻塞性睡眠呼吸暂停与非酒精性脂肪性肝病的关联:证据、机制及治疗
Nat Sci Sleep. 2024 Jul 8;16:917-933. doi: 10.2147/NSS.S468420. eCollection 2024.
7
Non-alcoholic fatty liver disease and sleep disorders.非酒精性脂肪性肝病与睡眠障碍。
World J Hepatol. 2024 Mar 27;16(3):304-315. doi: 10.4254/wjh.v16.i3.304.
8
The impact of obstructive sleep apnea on nonalcoholic fatty liver disease.阻塞性睡眠呼吸暂停对非酒精性脂肪性肝病的影响。
Front Endocrinol (Lausanne). 2023 Oct 2;14:1254459. doi: 10.3389/fendo.2023.1254459. eCollection 2023.
9
Effects of obstructive sleep apnea on non-alcoholic fatty liver disease in patients with obesity: a systematic review.肥胖患者阻塞性睡眠呼吸暂停对非酒精性脂肪性肝病的影响:系统评价。
Int J Obes (Lond). 2023 Dec;47(12):1200-1213. doi: 10.1038/s41366-023-01378-2. Epub 2023 Sep 11.
10
Management of non-alcoholic fatty liver disease patients with sleep apnea syndrome.非酒精性脂肪性肝病合并睡眠呼吸暂停综合征患者的管理。
World J Gastroenterol. 2022 Nov 21;28(43):6099-6108. doi: 10.3748/wjg.v28.i43.6099.